1. Adenoviral-bone morphogenetic protein-7 and/or doxazosin therapies promote the reversion of fibrosis/cirrhosis in a cirrhotic hamster model
   Daniel Cervantes-Garcia et al, 2017, Molecular Medicine Reports CrossRef
2. Decreased BMP‑7 and p‑Smad1/5/8 expression, and increased levels of gremlin in hepatocellular carcinoma
   Lina Wang et al, 2018, Oncology Letters CrossRef
3. Ellagic acid increases implantation rates with its antifibrotic effect in the rat model of intrauterine adhesion
   Gulistan Sanem Saribas et al, 2023, Pathology - Research and Practice CrossRef
4. BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration
   Blanca Herrera et al, 2017, International Journal of Molecular Sciences CrossRef
5. Bupleurum marginatum Wall.ex DC in Liver Fibrosis: Pharmacological Evaluation, Differential Proteomics, and Network Pharmacology
   Xiujie Liu et al, 2018, Frontiers in Pharmacology CrossRef
6. rSjp40 inhibits activated hepatic stellate cells by promoting nuclear translocation of YB1 and inducing BMP-7/Smad1/5/8 pathway
   Liuting Chen et al, 2019, Parasites & Vectors CrossRef
7. Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats
   Cheng Chi et al, 2018, BMC Complementary and Alternative Medicine CrossRef
8. Cpd861 Targeting BCL2 to Alleviate Hepatic Fibrosis: Network Pharmacology, Mendelian Randomization, and Molecular Docking Mechanisms
   Yaning Lyu et al, 2024, Current Pharmaceutical Design CrossRef
9. Novel Anti-fibrotic Therapies
   Benita L. McVicker et al, 2017, Frontiers in Pharmacology CrossRef
10. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula
    Hui Li, 2020, Journal of Ethnopharmacology CrossRef
11. Drugs and Targets in Fibrosis
    Xiaoyi Li et al, 2017, Frontiers in Pharmacology CrossRef